Proxy Results (Form 8-K)

Item 5.07 Submission of Matters to a Vote of Security Holders.

On December 18, 2025, Creative Medical Technology Holdings, Inc. (the "Company") held its 2025 Annual Meeting of Stockholders (the "Annual Meeting") to consider and vote on proposals for (i) the election of the director nominees named in the definitive proxy statement (the "Proxy Statement") for the Annual Meeting filed with the Securities and Exchange Commission on October 30, 2025 ("Proposal I"); (ii) the approval of the compensation of the Company's named executive officers ("Proposal II"); and (iii) the ratification of the appointment of Haynie & Company to serve as the Company's independent registered public accountants ("Proposal III"). Each of the foregoing proposals is described in more detail in the Proxy Statement. Stockholders holding an aggregate of 1,589,800 shares of common stock, representing 61.5% of the outstanding shares of the Company's common stock as of the record date, and which constituted a quorum, were present in person or represented by proxy at the Annual Meeting. The results of the voting at the Annual Meeting are presented below.

Proposal I - The five director nominees were all elected to the Board as follows:

Proposal II - The compensation of the Company's named executive officers was approved as follows:

Proposal III -The ratification of the appointment of Haynie & Company was approved as follows: